EBV gL-gH344-Ferritin Nanoparticle Vaccine Elicits Robust Immune Responses in Mice
Viruses · 2025
DOI: 10.3390/v17060754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Chenyu Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention,…. Hauptthemen laut MEDLINE: Ferritins, Nanoparticles, Herpesvirus 4, Human, Viral Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Key R&D Program of China.
Abstract (Originalsprache)
Considering the absence of a widely utilized EBV vaccine, we have developed an EBV gL-gH344-Ferritin nanoparticle vaccine utilizing ferritin as a carrier. The gL-gH344-Ferritin fusion gene was synthesized and inserted into the pET30a plasmid. The expression of the fusion protein in the recombinant plasmid was verified by Western blot. Then, the gL-gH344-Ferritin subunit nanoparticle vaccine was obtained by purification of the fusion protein. BALB/c mice were immunized using a two-dose protocol. The titers of EBV specific antibodies were determined using enzyme-linked immunosorbent assay at 4, 8, and 12 weeks after the initial immunization. Moreover, the levels of EBV gL-gH344 specific splenocytes secreting interferon (IFN)-γ and interleukin (IL)-6 were determined using an enzyme-linked immunospot assay. The pET30a-gL-gH344-Ferritin prokaryotic expression plasmid was successfully constructed. gL-gH344-Ferritin was efficiently expressed in E. coli. Following immunization with gL-gH344-Ferritin, the mice sera demonstrated elevated titers of EBV specific immunoglobulin G. Moreover, after stimulating with EBV gL-gH344 specific peptides, the splenocytes of the immunized mice showed a marked tendency to secrete large amounts of IFN-γ and IL-6. The gL-gH344-Ferritin nanoparticle vaccine carrying the EBV gL-gH344 fusion protein induced robust and sustained specific humoral and cellular immune responses in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, Ch…
- Hebei Key Laboratory for Chronic Diseases, School of Basic Medicine Sciences, North China University of Science and Technology, Tangshan 063210, China.
ORCID-Profile: Ke Xu, Yanzhe Hao
Förderung
- National Key Research and Development Program of China
- National Key R&D Program of China
Zitieren
APA
Li, C., Cao, Y., Ma, Q., Yang, J., Zhang, X., Li, H., Xu, K., Jiang, T., Li, S., Hao, Y., & Feng, X. (2025). EBV gL-gH344-Ferritin Nanoparticle Vaccine Elicits Robust Immune Responses in Mice. Viruses. https://doi.org/10.3390/v17060754
Vancouver
Li C, Cao Y, Ma Q, Yang J, Zhang X, Li H, et al. EBV gL-gH344-Ferritin Nanoparticle Vaccine Elicits Robust Immune Responses in Mice. Viruses. 2025. doi:10.3390/v17060754
BibTeX
@article{Li2025,
author = {Li, Chenyu and Cao, Yuxi and Ma, Qi and Yang, Jing and Zhang, Xiaoguang and Li, Hongxia and Xu, Ke and Jiang, Tao and Li, Shuying and Hao, Yanzhe and Feng, Xia},
title = {EBV gL-gH344-Ferritin Nanoparticle Vaccine Elicits Robust Immune Responses in Mice},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17060754}
}
EUVIMED